Your browser doesn't support javascript.
loading
Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.
Allison, Brett D; Phuong, Victor K; McAtee, Laura C; Rosen, Mark; Morton, Magda; Prendergast, Clodagh; Barrett, Terry; Lagaud, Guy; Freedman, Jamie; Li, Lina; Wu, Xiaodong; Venkatesan, Hariharan; Pippel, Marna; Woods, Craig; Rizzolio, Michèle C; Hack, Michael; Hoey, Kenway; Deng, Xiaohu; King, Christopher; Shankley, Nigel P; Rabinowitz, Michael H.
Affiliation
  • Allison BD; Johnson and Johnson Pharmaceutical Research and Development, LLC, 3210 Merryfield Row, San Diego, California 92121, USA.
J Med Chem ; 49(21): 6371-90, 2006 Oct 19.
Article in En | MEDLINE | ID: mdl-17034143
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Quinoxalines / Sulfonamides / Morpholines / Receptor, Cholecystokinin B / Ortho-Aminobenzoates Type of study: Diagnostic_studies Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2006 Type: Article Affiliation country: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Quinoxalines / Sulfonamides / Morpholines / Receptor, Cholecystokinin B / Ortho-Aminobenzoates Type of study: Diagnostic_studies Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2006 Type: Article Affiliation country: United States